• Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024

  • Aug 22 2024
  • Length: 11 mins
  • Podcast

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024

Listen for free

View show details

  • Summary

  • In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.

    Read the full coverage here:

    Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations

    Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease

    Inhibitor class PsO treatments exhibit similar efficacy in mitigating PsA risk

    S100 protein levels predict abatacept response in juvenile idiopathic arthritis

    Izokibep shows early promise in hidradenitis suppurativa

    References:

    Brunner HI, et al. Arthritis Res Ther. 2024;doi:10.1186/s13075-024-03347-0.

    Falasinnu T, et al. Lancet Rheumatol. 2024;doi:10.1016/S2665-9913(24)00120-6.

    Press Release

    Press Release

    Tsai SHL, et al. J Am Acad Dermatol. 2024;doi:10.1016/j.jaad.2024.07.1473.
    Show more Show less
Show more Show less

What listeners say about Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available